title: Methylprednisolone therapy in multiple sclerosis: a profile of adverse effects.
abstract: A retrospective analysis of 350 treatment courses using high dose pulsed intravenous methylprednisolone for relapses of multiple sclerosis revealed a low number of adverse effects. This study confirms that high dose methylprednisolone is a safe therapeutic option in multiple sclerosis.
authors.affiliation: Department of Neurology, Middlesbrough General Hospital, Cleveland, UK.
authors.forename: P R
authors.initials: PR
authors.lastname: Lyons
authors.forename: P K
authors.initials: PK
authors.lastname: Newman
authors.forename: M
authors.initials: M
authors.lastname: Saunders
mesh_terms: D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007262:Infusions, Intravenous; D008775:Methylprednisolone / Q000008:administration & dosage / Q000009:adverse effects*; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000188:drug therapy*; D011239:Prednisolone / Q000008:administration & dosage
chemical_list: D011239:Prednisolone; D008775:Methylprednisolone